SUMMARY OF OTHER SYNTHETICS
BILLS AND PROPOSED REGULATIONS
This project was supported by Cooperative Agreement No. 2012-DC-BX-K002 awarded by the Bureau of
Justice Assistance. The Bureau of Justice Assistance is a component of the Office of Justice Programs,
which also includes the Bureau of Justice Statistics, the National Institute of Justice, the office of Juvenile
Justice and Delinquency Prevention, the office for Victims of Crime, the Community Capacity
Development Office, and the Office of Sex Offender Sentencing, Monitoring, Apprehending, Registering,
and Tracking. Points of view or opinions in this document are those of the author and do not necessarily
represent the official position or policies of the U.S. Department of Justice.
© 2013 Research is current as of February 15, 2013. In order to ensure that the information contained herein is as current as
possible, research is conducted using both nationwide legal database software and individual state legislative websites. Please
contact Heather Gray at (703) 836-6100, ext. 114 or [email protected] with any additional updates or information that may be
relevant to this document. This document is intended for educational purposes only and does not constitute legal advice or
opinion. Headquarters Office: THE NATIONAL ALLIANCE FOR MODEL STATE DRUG LAWS. 215 Lincoln Ave. Suite
201, Santa Fe, NM 87501.
BILLS –
Arizona:
H.B. 2327 – Passed third reading 2/12/2013
- adds 2C-C, 2C-D, 2C-E, 2C-H, 2C-I, 2C-N, 2C-P, 2C-T-2, 2C-T-4
D.C.:
L.B. 645 (B19-645) – enacted 2/13/2013
- adds 2C-C, 2C-D, 2C-E, 2C-H, 2C-I, 2C-N, 2C-P, 2C-T-2, 2C-T-4, 2C-T-7, 5-MeO-DiPT,
AMT
L.B. 1109 (B19-1109) – Signed by Mayor; effective on signing 1/14/2013
- adds 2C-C, 2C-D, 2C-E, 2C-H, 2C-I, 2C-N, 2C-P, 2C-T-2, 2C-T-4, 2C-T-7, 5-MeO-DiPT,
AMT
Florida:
H.B. 619 – Referred to committee; on committee agenda for 2/19 2/12/2013
- adds 2C-D, 2C-H, 2C-N, 2C-P, 25I-NBOMe, APB, APDB, fluoroamphetamine,
fluoromethamphetamine, MPA, MXE
S.B. 294 – In judiciary committee 2/6/2013
- adds 2C-D, 2C-H, 2C-N, 2C-P, 25I-NBOMe, APB, APDB, fluoroamphetamine,
fluoromethamphetamine, MPA, MXE
Georgia:
H.B. 302 – House second readers 2/13/2013
- adds 2C-C, 2C-I, 25B-NBOMe, 25C-NBOMe, 25I-NBOMe, 5-MeO-DALT
Indiana:
H.B. 1382 – Committee report to pass adopted 2/14/2013
- adds 2C-C, 2C-D, 2C-E, 2C-H, 2C-I, 2C-N, 2C-P, 2C-T-2, 2C-T-4, 5-MeO-DMT
S.B. 536 – Committee report to pass as amended adopted 1/31/2013
- adds 2C-C-NBOMe, 25I-NBOMe
Kentucky:
H.B. 8 – 2nd reading; to committee; posted for passage in the Consent Orders of the Day for
Friday, February 15, 2013 2/15/2013
- adds 2,5B-NBOMe, 2,5C-NBOMe, 2,5H-NBOMe, 2,5I-NBOMe
Louisiana:
H.B. 10 – first appeared on the interim calendar 2/8/2013
- adds 2C-C, 2C-D, 2C-E, 2C-H, 2C-I, 2C-N, 2C-P, 25C-NBOMe, 25I-NBOH, 25I-NBOME,
2C-T-2, 2C-T-4, 4-FA, 4-FMA, 4-HO-DIPT, 5-APB, 5-APDB, 5-IAI, 5-MeO-DALT, 5-MeODMT, 5-MeO-MIPT, 6-APB, 6-APDB, DIPT, MXE
© 2013 Research is current as of February 15, 2013. In order to ensure that the information contained herein is as current as
possible, research is conducted using both nationwide legal database software and individual state legislative websites. Please
contact Heather Gray at (703) 836-6100, ext. 114 or [email protected] with any additional updates or information that may be
relevant to this document. This document is intended for educational purposes only and does not constitute legal advice or
opinion. Headquarters Office: THE NATIONAL ALLIANCE FOR MODEL STATE DRUG LAWS. 215 Lincoln Ave. Suite
201, Santa Fe, NM 87501.
Maryland:
H.B. 483 – unfavorable report by Judiciary, withdrawn by sponsor 2/13/2013
- adds 2C-B
Massachusetts:
H.B. 4383 – no further action taken 1/1/2013
- adds MPHP
Montana:
H.B. 140 – Referred to Senate committee; scheduled for hearing 3/12 2/7/2013
- adds AMT, 2C-T-7, 5-MeO-DIPT, 5-MeO-DMT
Nebraska:
L.B. 298 – Referred to committee 1/22/2013
- adds phenethylamines language with the following as examples: 2,5-DMA, 2C-B, 2C-C, 2C-D,
2C-E, 2C-H, 2C-I, 2C-N, 2C-P, 2C-T, 2C-B-butterFLY, 2C-B-FLY, 2CB-5-hemiFLY, 2C-BFLY-NBOMe, 2C-B-NBOMe, 2C-I-NBOH, 2C-T-2, 2C-T-4, 2C-T-7, 5-APB, 5-APDB, 6-APB,
6-APDB, bromo-dragonFLY, DOB, DOC, DOI
- adds substituted tryptamines language with the following as examples: 4-AcO-DMT, 4-HODIPT, 4-HO-MET, 5-MeO-DALT, 5-MeO-DIPT, 5-MeO-DMT, 5-MeO-MIPT
New York:
A.B. 1285 – Referred to committee 1/9/2013
- adds TFMPP
S.B. 2441 – Referred to committee 1/17/2013
- adds 2-AI, 2C-C, 2C-D, 2C-E, 2C-B-FLY, 3C-B-FLY, 3-MeO-PCE, 4-MeO-PCP, 5-IAI, 5MeO-DALT, 5-MeO-DIPT, 6-APB, bromo-dragonFLY, MXE
North Dakota:
H.B. 1070 – Passed House; referred to Senate committee 2/12/2013
- adds substituted phenethylamines language with the following as examples: 2,5-DMA, 2C-B,
2C-C, 2C-D, 2C-E, 2C-H, 2C-I, 2C-N, 2C-P, 2C-T, 2C-B-butterFLY, 2C-B-FLY, 2CB-5hemiFLY, 2C-B-FLY-NBOMe, 2C-B-NBOMe, 2C-C-NBOMe, 2C-I-NBOH, 2C-I-NBOMe,
2C-T-2, 2C-T-4, 2C-T-7, 5-APB, 5-APDB, 6-APB, 6-APDB, bromo-dragonFLY, DOB, DOC,
DOI, mescaline-NBOMe
- adds substituted tryptamines language with the following as examples: 4-AcO-DMT, 4-HODIPT, 4-HO-MET, 5-MeO-DALT, 5-MeO-DIPT, 5-MeO-DMT, 5-MeO-MiPT, MXE, TFMPP
- adds fluoroamphetamine, fluoromethamphetamine
Ohio:
H.B. 334 – signed by Governor; effective on signing 12/20/2012
- adds 2C-C, 2C-D, 2C-E, 2C-I, 2C-H, 2C-N, 2C-P, 25I-NBOMe, 2C-T-2, 2C-T-4, 5-APB, 5APDB, 5-IAI, 5-MeO-DALT, 6-APB, 6-APDB, BTCP, MPA, MXE, PMMA
© 2013 Research is current as of February 15, 2013. In order to ensure that the information contained herein is as current as
possible, research is conducted using both nationwide legal database software and individual state legislative websites. Please
contact Heather Gray at (703) 836-6100, ext. 114 or [email protected] with any additional updates or information that may be
relevant to this document. This document is intended for educational purposes only and does not constitute legal advice or
opinion. Headquarters Office: THE NATIONAL ALLIANCE FOR MODEL STATE DRUG LAWS. 215 Lincoln Ave. Suite
201, Santa Fe, NM 87501.
Oklahoma:
H.B. 2217 – Amended by committee substitute; committee recommends do pass 2/14/2013
- adds 2C-H, 25C-NBOMe, 25I-NBOMe, 2C-T-7, 4-FA, 4-FMA, DBZP
Rhode Island:
H.B. 5325 - Referred to committee 2/7/2013
- adds TFMPP
South Dakota:
S.B. 68 – Committee recommends do pass 2/12/2013
- adds 5-MeO-DMT
- adds substituted phenethylamines language with the following as examples: 2C-T, DOB, DOC,
DOI, 2C-B-NBOMe, 2C-B-NBOMe (different structure), mescaline-NBOMe, 2C-C-NBOMe,
2CB-5-hemiFLY, 2C-B-FLY, 2C-B-butterFLY, 2C-B-FLY-NBOMe, bromo-dragonFLY, 2C-INBOH, 5-APB, 5-APDB, 6-APB, 6-APDB
- adds substituted tryptamines language with the following as examples: 5-MeO-DALT, 4-AcODMT, 4-HO-MET, 4-HO-DIPT, 5-MeO-MIPT
- adds DBP, fluoroamphetamine, fluoromethamphetamine, MCPP, pFPP, pMeOPP
Tennessee:
H.B. 12 – Introduced 1/28/2013
- adds hydroxylmitragynine, mitragynine
S.B. 48 – Referred to committee 1/30/2013
- adds hydroxylmitragynine, mitragynine
Texas:
S.B. 264 – Referred to committee 1/29/2013
- adds 25I-NBOMe
Utah:
H.B. 52 – Draft of enrolled bill prepared 2/8/2013
- adds 2C-C, 2C-D, 2C-E, 2C-H, 2C-I, 2C-N, 2C-P, 25I-NBOMe, 2C-T-2, 2C-T-4, 5-IAI, 5MeO-DALT, DiPT, DOC, fluoromethamphetamine, MXE
Virginia:
H.B. 1843 – Incorporated by Courts of Justice into H.B. 1941 1/25/2013
- adds 2C-C, 2C-D, 2C-H, 2C-N, 2C-P, 2C-B-MBOMe, 2C-C-NBOMe, 2C-T-2, 2C-T-4, APB,
APDB
H.B. 1941 – passed House; constitutional reading dispensed 2/15/2013
- adds 2C-C, 2C-D, 2C-H, 2C-N, 2C-P, 2C-B-NBOMe, 2C-C-NBOMe, 2C-T-2, 2C-T-4, APB,
APDB
© 2013 Research is current as of February 15, 2013. In order to ensure that the information contained herein is as current as
possible, research is conducted using both nationwide legal database software and individual state legislative websites. Please
contact Heather Gray at (703) 836-6100, ext. 114 or [email protected] with any additional updates or information that may be
relevant to this document. This document is intended for educational purposes only and does not constitute legal advice or
opinion. Headquarters Office: THE NATIONAL ALLIANCE FOR MODEL STATE DRUG LAWS. 215 Lincoln Ave. Suite
201, Santa Fe, NM 87501.
S.B. 1083 – read 2nd time in House 2/14/2013
- adds 2C-C, 2C-D, 2C-H, 2C-N, 2C-P, 2C-B-NBOMe, 2C-C-NBOMe, 2C-T-2, 2C-T-4, APB,
APDB
S.B. 1318 – Incorporated by Courts of Justice into S.B. 1083 1/23/2013
- adds 2C-C, 2C-D, 2C-H, 2C-N, 2C-P, 2C-B-MBOMe, 2C-C-NBOMe, 2C-T-2, 2C-T-4, APB,
APDB
REGULATIONS –
2012 FL REG TEXT 312013 (FL AD 2ER12-1) – Emergency rules; enacted 12/12/2012
- adds 2C-D, 2C-H, 2C-N, 2C-P, 25I-NBOMe, APB, APDB, fluoroamphetamine,
fluoromethamphetamine, MPA, MXE
2013 IN REG TEXT 315727 (856 IAC 2-2-2) – Enacted 1/23/2013
- adds 2C-C-NBOMe, 25I-NBOMe
2013 KY REG TEXT 316454 – Approved; effective 12/19 12/12/2012
- adds 2,5B-NBOMe, 2,5C-NBOMe, 2,5H-NBOMe
2013 KY REG TEXT 316510 – Approved; effective 12/19 12/12/2012
- adds 2,5B-NBOMe, 2,5C-NBOMe, 2,5H-NBOMe
2012 LA REG TEXT 310618 (LAC 46:LIII.2704) – Emergency rules; enacted 11/20/2012
- adds 25I-NBOMe
2013 MI REG TEXT 316585 (R338.3101 through R338.3199q) – emergency regulations; takes
effect upon filing with the Secretary of State and remains in effect for six months 2/1/2013
- adds 2C-C, 2C-D, 2C-E, 2C-H, 2C-I, 2C-N, 2C-P, 2C-T, 2C-B-butterFLY, 2C-B-FLY, 2CB-5hemiFLY, 2C-B-FLY-NBOMe, 2C-B-NBOMe, 2C-C-NBOMe, 2C-I-NBOH, 2C-I-NBOMe,
2C-T-2, 2C-T-4, 2C-T-7, 5-APB, 5-APDB, 6-APB, 6-APDB, bromo-dragonFLY, DOB, DOC,
DOI, mescaline-NBOMe
2012 NV REG TEXT 310060 (NAC 453.510) – Public hearing scheduled 1/17/2013
- adds 2C-C, 2C-D, 2C-E, 2C-H, 2C-I, 2C-N, 2C-P, 2C-T-2, 2C-T-4
2013 NY REG TEXT 305188 (10 NYCRR 9.1, 2, 3, 4, 5, 6) – Enacted on emergency basis
11/5/2012; Adopted 1/2/2013
- adds 2C-C, 2C-D, 2C-E, 2C-H, 2C-I, 2C-N, 2C-P, 2C-T-2, 2C-T-4
2012 ND REG TEXT 312282 (ADC 61-13-01-01, 02, 03) – Enacted on emergency basis
12/3/2012; Hearing scheduled 1/9/2013
- adds substituted phenethylamines language with the following as examples: 2,5-DMA, 2C-B,
2C-C, 2C-D, 2C-E, 2C-H, 2C-I, 2C-N, 2C-P, 2C-T, 2C-B-butterFLY, 2CB-5-hemiFLY, 2C-BFLY-NBOMe, 2C-B-NBOMe, 2C-C-NBOMe, 2C-I-NBOH, 2C-I-NBOMe, 2C-T-2, 2C-T-4,
© 2013 Research is current as of February 15, 2013. In order to ensure that the information contained herein is as current as
possible, research is conducted using both nationwide legal database software and individual state legislative websites. Please
contact Heather Gray at (703) 836-6100, ext. 114 or [email protected] with any additional updates or information that may be
relevant to this document. This document is intended for educational purposes only and does not constitute legal advice or
opinion. Headquarters Office: THE NATIONAL ALLIANCE FOR MODEL STATE DRUG LAWS. 215 Lincoln Ave. Suite
201, Santa Fe, NM 87501.
2C-T-7, 5-APB, 5-APDB, 6-APB, 6-APDB, bromo-dragonFLY, DOB, DOC, DOET, DOI,
DOB, MDA, MDEA, mescaline-NBOMe
- adds substituted tryptamines language with the following as examples: 4-AcO-DMT, 4-HODIPT, 4-HO-MET, 5-MeO-DALT, 5-MeO-DIPT, 5-MeO-DMT, 5-MeO-MIPT, DET, DMT,
MXE, pTFMPP
- adds fluoroamphetamine, fluoromethamphetamine
2012 VT REG TEXT 306843 (ADC 12-5-23:I – VIII) – Enacted on emergency basis; in effect
until 4/20/2013 12/21/2012
- adds 2-FMA, 2-MeO-ketamine, 2C-B, 2C-C, 2C-D, 2C-E, 2C-H, 2C-I, 2C-N, 2C-P, 2C-BFLY-NBOMe, 25B-NBOMe, 2CBCB-NBOMe, 2C-C-NBOMe, 2C-T-2, 2C-T-4, 2C-T-7, 2CTFM-NBOMe, 25I-NBF, 25I-NBMD, 25I-NBOH, 25I-NBOMe, 3-HO-PCE, 3-HO-PCP, 3MeO-PCP, 4-AcO-DET, 4-AcO-DMT, 4-AcO-DPT, 4-FA, 4-FMA, 4-HO-MET, 4-HO-MIPT,
4-HO-MPMI, 4-HO-MPT, 4-MeO-AET, 4-MeO-MIPT, 4-MeO-PCP, 4-methyl-AET, 5-APB, 5ME, 5-MeO-AMT, 5-MeO-DALT, 5-MeO-DET, 5-MeO-DIPT, 5-MeO-DMT, 5-MeO-DPT, 5MeO-MIPT, 5-MeO-MPMI, 6-APB, DBZP, DIPT, DPT, ethyl-ketamine, Kratom, MCPP,
MeOPP, MIPT, MPA, MXE, O-DT, pFPP, TFMPP
2012 VT REG TEXT 311487 (ADC 12-5-23:I – VIII) – Adopted; effective 3/2/2013 1/31/2013
- adds 2-FMA, 2-MeO-ketamine, 2C-B, 2C-C, 2C-D, 2C-E, 2C-H, 2C-I, 2C-N, 2C-P, 2C-BFLY-NBOMe, 25B-NBOMe, 2CBCB-NBOMe, 2C-C-NBOMe, 2C-T-2, 2C-T-4, 2C-T-7, 2CTFM-NBOMe, 25I-NBF, 25I-NBMD, 25I-NBOH, 25I-NBOMe, 3-HO-PCE, 3-HO-PCP, 3MeO-PCP, 4-AcO-DET, 4-AcO-DMT, 4-AcO-DPT, 4-FA, 4-FMA, 4-HO-MET, 4-HO-MIPT,
4-HO-MPMI, 4-HO-MPT, 4-MeO-AET, 4-MeO-MIPT, 4-MeO-PCP, 4-methyl-AET, 5-APB, 5ME, 5-MeO-AMT, 5-MeO-DALT, 5-MeO-DET, 5-MeO-DIPT, 5-MeO-DMT, 5-MeO-DPT, 5MeO-MIPT, 5-MeO-MPMI, 6-APB, 7-hydroxymitragynine, DBZP, DIPT, DPT, ethyl-ketamine,
MCPP, MeOPP, MIPT, MPA, MXE, pFPP, TFMPP
2013 VT REG TEXT 317654 (ADC 12-5-23:I – VIII) – emergency rules 2/13/2013
- adds 2-FMA, 2-MeO-ketamine, 2C-B, 2C-C, 2C-D, 2C-E, 2C-H, 2C-I, 2C-N, 2C-P, 2C-BFLY-NBOMe, 25B-NBOMe, 2CBCB-NBOMe, 2C-C-NBOMe, 2C-T-2, 2C-T-4, 2C-T-7, 2CTFM-NBOMe, 25I-NBF, 25I-NBMD, 25I-NBOH, 25I-NBOMe, 3-HO-PCE, 3-HO-PCP, 3MeO-PCP, 4-AcO-DET, 4-AcO-DMT, 4-AcO-DPT, 4-FA, 4-FMA, 4-HO-MET, 4-HO-MIPT,
4-HO-MPMI, 4-HO-MPT, 4-MeO-AET, 4-MeO-MIPT, 4-MeO-PCP, 4-methyl-AET, 5-APB, 5MeO-AMT, 5-MeO-DALT, 5-MeO-DET, 5-MeO-DIPT, 5-MeO-DMT, 5-MeO-DPT, 5-MeODIPT (different structure; may be 5-MeO-MIPT), 5-MeO-MPMI, 6-APB, 7hydroxymitragynine, DIPT, DPT, ethyl-ketamine, MCPP, MeOPP, MIPT, MPA, MXE, pFPP,
TFMPP
* Red text indicates the legislative session has adjourned sine die.
© 2013 Research is current as of February 15, 2013. In order to ensure that the information contained herein is as current as
possible, research is conducted using both nationwide legal database software and individual state legislative websites. Please
contact Heather Gray at (703) 836-6100, ext. 114 or [email protected] with any additional updates or information that may be
relevant to this document. This document is intended for educational purposes only and does not constitute legal advice or
opinion. Headquarters Office: THE NATIONAL ALLIANCE FOR MODEL STATE DRUG LAWS. 215 Lincoln Ave. Suite
201, Santa Fe, NM 87501.